• EZ Cap Cy5 Firefly Luciferase mRNA Workflow

  2026-08-20

  Build a quantitative mRNA delivery workflow that separates cellular uptake from functional protein expression in the same experiment. This dual-reporter reagent combines Cy5 tracking with Firefly Luciferase output, making it useful for transfection optimization, intracellular trafficking, and translational vaccine research.

• Removing Pollen Interference in EEM Bioaerosol Detection

  2026-08-20

  Zhang et al. developed a fluorescence-data transformation and random-forest workflow to reduce pollen interference during hazardous bioaerosol classification. In the reference study, fast Fourier transform processing improved classification performance to 89.24%, supporting more reliable discrimination of selected pathogens and toxins.

• Tetracycline Hydrochloride Assay Workflows

  2026-08-19

  Build reproducible bacterial growth, Staphylococcus aureus susceptibility, and skin microbiome workflows with a mechanism-matched tetracycline control. This guide also shows how to distinguish ribosomal translation inhibition from the rapid ROS-driven cancer-cell death reported for carrier-platin.

• Calcitriol Workflows for VDR and Decidualization

  2026-08-19

  Use Calcitriol, the active 1,25-dihydroxy vitamin D3 metabolite, to connect vitamin D receptor signaling with endometrial decidualization, immune modulation research, and cancer pathway assays. This practical guide emphasizes solvent handling, time-course design, orthogonal readouts, and troubleshooting for reproducible results.

• EdU Imaging Kits (HF594): S-Phase in Context

  2026-08-18

  EdU Imaging Kits (HF594) enable precise S-phase DNA synthesis measurement without harsh DNA denaturation. This guide shows how to interpret proliferation alongside Treg differentiation and metabolic mechanisms highlighted in recent asthma research.

• Carfilzomib (PR-171) in Proteasome Research

  2026-08-18

  Carfilzomib (PR-171) enables precise, irreversible proteasome inhibition for studying proteotoxic stress, apoptosis, and combination responses. This workflow translates recent ESCC radiosensitization findings into practical cell-based assays while emphasizing solvent control, orthogonal readouts, and reproducible dosing.

• MPTP Opening as a Translational Cell-Death Signal

  2026-08-17

  A mechanistic and strategic guide to using MPTP opening as a functional bridge between mitochondrial dysfunction, intrinsic apoptosis, and translational cell-death research.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike Binding

  2026-08-17

  The 2025 reference study shows that naturally occurring angiotensin peptides can modify SARS-CoV-2 spike-protein binding to AXL, ACE2, and NRP1 in antibody-based assays. Its peptide-truncation and residue-modification strategy identifies angiotensin IV and related shorter peptides as stronger enhancers than the longer Angiotensin I decapeptide, while also defining important limits for interpreting these findings in infection or cardiovascular models.

• Neuroligin 1 Proteolysis Sustains Social Memory

  2026-08-16

  Liu and colleagues show that social interaction initiates α- and γ-secretase-dependent cleavage of Neuroligin 1 in the ventral hippocampus, generating an intracellular NLG1-CTD fragment that supports synaptic remodeling and social memory maintenance. The study combines behavioral, genetic, pharmacological, biochemical, and peptide-rescue approaches to connect extracellular social cues with cofilin-regulated spine plasticity.

• From Calpain Biology to Translational Cancer Strategy

  2026-08-15

  Calpain Inhibitor II, ALLM offers a practical way to interrogate protease-dependent apoptosis and protein turnover. This thought-leadership article connects calpain-2–FAK regulation in triple-negative breast cancer with assay strategy in leukemia and lymphoma, while defining what ALLM can—and cannot—prove in translational research.

• YC-1 Workflows for Hypoxia Cancer Research

  2026-08-14

  Build more informative hypoxia experiments with YC-1 by pairing HIF-1α pathway measurements with viability, angiogenesis, and soluble guanylyl cyclase readouts. This guide adapts a rigorously staged fluorometric assay framework to improve formulation control, interference testing, dose–response analysis, and mechanism-aware interpretation.

• H 89 2HCl: Reliable PKA Pathway Assays

  2026-08-14

  Learn how H 89 2HCl (SKU B2190) can clarify cAMP/PKA signaling in viability, proliferation, phosphorylation, and osteoclastogenesis workflows. This scenario-based guide covers solvent compatibility, concentration selection, assay controls, off-target interpretation, and practical supplier evaluation.

• NVP-BGJ398 Phosphate: Reading FGFR3 Evidence

  2026-08-13

  NVP-BGJ398 phosphate is a potent FGFR1–3 inhibitor for dissecting pathway-dependent phenotypes in cancer and skeletal disease models. This article focuses on how to interpret genetic, pharmacological, signaling, and tissue-level evidence without confusing pathway inhibition with disease-specific efficacy.

• MTT Assay Workflows for Cell Viability Research

  2026-08-13

  Build more reliable colorimetric cell viability assays with MTT by controlling cell density, formazan solubilization, plate effects, and metabolic confounders. A lung cancer and mesenchymal stem cell study shows how MTT can anchor a broader workflow that connects viability results with proliferation, migration, invasion, and pathway analyses.

• CARMIL Membrane Binding Controls Actin Assembly

  2026-08-12

  The reference study identifies the CARMIL membrane-binding domain as an active regulator of capping protein rather than a passive membrane tether. Its results support a dynamic model in which CARMIL recruits capping protein and actin assembly machinery to membranes, then disengages after capping protein binding to promote uncapping and soluble capping-protein activity.

16260 records 1/1084 page Next 12345 下5页 Last page